NSCLC, adenocarcinoma, LUL, cT2aNoM1, stage IV, with bone metastasis, status post Afatinib (2015/10-2016/12),s/p palliative R/T to bone metastases(2016/5-2016/8), disease progression, s/p Cisplatin and Alimta C1D1 on 2017/01/04

poor response to prone position
Hypoxia improved
Fever subsided after Mepam

=> weaning if feasible